YOLFTbeta
30

SMO ClinPlus Co. Ltd.

301257 · SHE · Healthcare / Diagnostics & Research

33.87CNY-1.30 (-3.70%)

Price History

Full chart

Market Stats

Previous Close35.17
Open34.55
Day Range33.56 – 35.47
52-Week Range34.49 – 84.85
Volume2.17M
Market Cap3.37B
P/E (TTM)59.32
Forward P/E0.00
EPS0.72
Dividend Yield0.35%
Beta0.86
50-Day Avg43.00
200-Day Avg52.72

About

SMO ClinPlus CO.,LTD. provides site management services in research and development in pharmaceuticals, medical devices, and health-related products in China. It offers clinical trial site management organization services to pharmaceuticals, medical devices, CRO companies, etc. The company offers preliminary modeling and preparation plans, trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Huangpu, China.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Hongwei Yang
  • Employees4.60K
  • HeadquartersShanghai World Trade Tower, Huangpu, China, 200001, China
  • Websitehttps://www.smo-clinplus.com

Leadership

  • Mr. Hongwei YangFounder, GM & Director · b. 1977
  • Ms. Weihong SongDirector of Finance & Accounting Supervisor · b. 1971
  • Mr. Xiaolong LaiBoard Secretary & Non-Independent Director · b. 1972
  • Ms. Xia ChenDeputy General Manager · b. 1986
  • Ms. Yue WangDeputy General Manager · b. 1982
  • Ms. Ting ChangDeputy General Manager · b. 1983
  • Ms. Jing ZhaoDeputy General Manager · b. 1985

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue303.54M335.29M502.97M586.23M760.04M803.73M842.50M
Growth (%)-+10.46%+50.01%+16.55%+29.65%+5.75%+4.82%
Cost of Revenue203.75M237.64M371.77M426.25M528.94M607.75M624.56M
Gross Profit99.80M97.65M131.19M159.98M231.10M195.98M217.95M
Gross Margin32.88%29.12%26.08%27.29%30.41%24.38%25.87%
Operating Expense38.67M50.75M57.86M80.64M76.08M80.89M83.61M
Operating Income61.13M46.90M73.33M79.35M155.02M115.09M134.34M
Operating Margin20.14%13.99%14.58%13.54%20.40%14.32%15.95%
EBITDA62.36M49.21M73.94M89.47M172.19M134.92M143.72M
EBITDA Margin20.54%14.68%14.70%15.26%22.66%16.79%17.06%
Net Income52.36M35.32M57.77M72.41M134.73M106.43M109.64M
Net Income Margin17.25%10.53%11.49%12.35%17.73%13.24%13.01%
R&D16.38M14.99M21.19M32.23M34.75M35.84M38.77M
R&D as % of Total Revenue5.40%4.47%4.21%5.50%4.57%4.46%4.60%
Interest Expense966.66-268.63K179.08K323.49K443.20K200.75K
Interest Expense % of Total Revenue0.00%-0.05%0.03%0.04%0.06%0.02%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets201.93M292.39M404.25M1.16B1.37B1.43B1.54B
Total Liabilities76.74M127.43M175.41M208.75M286.22M256.48M274.41M
Total Equity125.19M164.96M228.84M951.97M1.08B1.17B1.27B
Cash89.56M103.03M135.65M677.45M493.33M488.98M467.28M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow45.53M22.45M41.52M40.44M114.85M-1.07M35.69M
Capital Expenditure4.91M4.08M4.40M7.95M10.25M9.22M7.83M
Free Cash Flow40.62M18.36M37.11M32.48M104.60M-10.29M27.86M
Dividends Paid1.69K---10.74M22.08M13.32M
FCF to OCF89.21%81.81%89.39%80.33%91.08%962.32%78.06%
Dividend Paid to FCF0.00%---10.27%-214.55%47.82%

Earnings

Report DateSep 30, 2022Dec 31, 2022Apr 26, 2023Aug 27, 2023Oct 29, 2023Dec 31, 2023Apr 28, 2024Jun 30, 2024Oct 29, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------
EPS Actual0.240.420.420.600.640.430.370.400.220.430.090.600.420.280.15-0.12
Surprise----------------
Timing--Pre-marketAfter-hoursPre-market-Pre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap3.37B
Enterprise Value2.75B
Trailing P/E59.32
Forward P/E0.00
Price / Sales4.09
Price / Book2.63
EPS0.72
Book Value16.02
Revenue (TTM)824.77M
Gross Profit (TTM)164.10M
EBITDA44.19M
Profit Margin7.04%
Operating Margin-17.58%
Return on Equity4.67%
Return on Assets1.58%
Shares Outstanding79.00M
Shares Float46.75M
Beta0.86
Dividend Yield0.35%
Dividend Rate0.15
Payout Ratio20.15%

Dividends

20261×
0.08Jul 9, 2026
20252×
0.07Nov 28, 20250.10Jun 20, 2025
20242×
0.15Oct 10, 20240.13Jun 6, 2024
20232×
0.05Dec 11, 20230.08Jul 6, 2023

Stock Splits

  • Jun 6, 20241.3:1